The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.65
Bid: 2.60
Ask: 2.70
Change: 0.125 (4.95%)
Spread: 0.10 (3.846%)
Open: 2.525
High: 2.65
Low: 2.525
Prev. Close: 2.525
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

2 Jun 2017 11:30

RNS Number : 0105H
Stockdale Securities Limited
02 June 2017
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stockdale Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brave Bison Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

As above

(d) Date dealing undertaken:

01 06 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Sale

36,944

1.34p

1.34p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

02 June 2017

Contact name:

Andrew Proctor

Telephone number:

0207 601 6106

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERZMGGVGZRGNZM
Date   Source Headline
4th Aug 20158:28 amRNSRightster partners with Procter & Gamble
28th Jul 20157:00 amRNSTrading Update
7th Jul 20153:39 pmRNSIssue of Equity
1st Jul 201512:15 pmRNSPartnership with Universal Pictures International
23rd Jun 20159:50 amRNSProcter & Gamble partnership deals
17th Jun 20153:44 pmRNSDirector/PDMR Shareholding
26th May 20152:37 pmRNSResult of General Meeting
21st May 20157:00 amRNSContract Win
7th May 20157:01 amRNSFurther re: Proposed Placing
7th May 20157:00 amRNSFinal Audited Results
30th Apr 20156:25 pmRNSProposed Placing
29th Apr 20157:01 amRNSDirectorate Change
17th Apr 201511:28 amRNSContract Win
10th Apr 201510:05 amRNSIssue of Equity
25th Feb 20157:02 amRNSBusiness Update
17th Feb 20157:00 amRNSIssue of Equity
28th Jan 20153:30 pmRNSDirectorate Change
28th Jan 20153:30 pmRNSTrading Update
30th Dec 20147:00 amRNSDirector/PDMR Shareholding
23rd Dec 201411:51 amRNSIssue of Equity
15th Dec 20147:00 amRNSAppointment of New CFO
2nd Dec 20144:16 pmRNSIssue of Equity
21st Nov 20143:05 pmRNSRightster Partners With Sony Music Entertainment
7th Nov 20147:00 amRNSQ3 2014 Business Update
29th Sep 20147:00 amRNSContract Win
25th Sep 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:03 amRNSHalf Yearly Report
19th Aug 20148:40 amRNSIssue of Equity
1st Aug 20141:50 pmRNSCompletion of Base79 Limited Acquisition
30th Jul 20142:36 pmRNSDirector/PDMR Shareholding
28th Jul 20148:24 amRNSAdmission to AIM and Total Voting Rights
25th Jul 201412:00 pmRNSResult of GM
18th Jul 20148:35 amRNSDirector/PDMR Shareholding
8th Jul 20147:00 amRNSAcquisitions and Placing
8th Jul 20147:00 amRNSH1 Business Update
1st Jul 20147:00 amRNSChange of Registered Office
11th Jun 20142:05 pmRNSResult of AGM
5th Jun 20147:00 amRNSBarcroft Partnership
29th May 20147:00 amRNSIssue of Equity
19th May 20144:10 pmRNSPosting of Annual Report and AGM Notice
16th Apr 201411:31 amRNSFinal Results
9th Apr 20147:00 amRNSQ1 Business Update
4th Feb 20147:00 amRNSTrading Statement
5th Dec 20137:00 amRNSNew Deals in Sports, News and Entertainment
12th Nov 20137:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.